Skip to main content

Table 4 Risk of SPC by first and second cancer site among male patients, France 1989–2004 (N = 160,807)

From: The effect of patient characteristics on second primary cancer risk in France

First cancer site

Second cancer site

O

E

PYR

SIRa

EARa,b

(95% CI)

Lip

Lung, bronchus and trachea

27

9.52

4,081

2.84

42.8

(20.3-72.9)

 

Oesophagus

7

1.79

 

3.91

12.8

(2.5-31.0)

Head and neck

Lung, bronchus and trachea

663

76.15

38,731

8.71

151.5

(138.7-165.1)

 

Head and neckc

405

24.54

 

16.50

98.2

(88.3-108.9)

 

Oesophagus

269

13.79

 

19.51

65.9

(57.8-74.7)

 

Larynx

76

10.74

 

7.07

16.8

(12.7-21.8)

 

Colorectum

109

60.09

 

1.81

12.6

(7.6-18.4)

 

Liver, primary

62

17.04

 

3.64

11.6

(7.9-16.1)

 

Bladder

53

24.13

 

2.20

7.5

(4.0-11.7)

 

Kidney

35

17.32

 

2.02

4.6

(1.8-8.1)

 

Pancreas

26

11.03

 

2.36

3.9

(1.5-7.0)

 

Stomach

29

14.27

 

2.03

3.8

(1.3-7.1)

Oesophagus

Head and neck

92

6.29

7,367

14.63

116.3

(92.1-144.6)

 

Lung, bronchus and trachea

71

16.70

 

4.25

73.7

(52.6-98.9)

 

Larynx

16

2.25

 

7.11

18.7

(9.4-32.2)

 

Colorectum

25

14.51

 

1.72

14.2

(2.3-30.4)

 

Stomach

10

3.72

 

2.69

8.5

(1.5-19.9)

 

Bladder

12

5.96

 

2.01

8.2

(0.3-20.4)

Colorectum

Colorectumc

174

119.63

97,268

1.45

5.6

(3.0-8.5)

 

Lung, bronchus and trachea

279

240.30

 

1.16

4.0

(0.7-7.5)

 

Bladder

136

104.92

 

1.30

3.2

(0.9-5.8)

Larynx

Lung, bronchus and trachea

310

44.71

19,900

6.93

133.3

(116.5-151.7)

 

Head and neck

138

15.78

 

8.75

61.4

(50.3-74.0)

 

Oesophagus

64

7.59

 

8.43

28.3

(21.0-37.3)

 

Bladder

46

16.25

 

2.83

15.0

(8.8-22.7)

 

Colorectum

62

39.40

 

1.57

11.4

(4.1-20.1)

 

Liver, primary

22

10.72

 

2.05

5.7

(1.5-11.4)

 

Stomach

19

9.27

 

2.05

4.9

(1.1-10.3)

 

Pancreas

14

6.96

 

2.01

3.5

(0.3-8.3)

Lung, bronchus and trachea

Head and neck

127

31.83

41,162

3.99

23.1

(18.0-29.0)

 

Bladder

105

34.29

 

3.06

17.2

(12.5-22.5)

 

Oesophagus

55

15.65

 

3.51

9.6

(6.3-13.6)

 

Colorectum

121

84.25

 

1.44

8.9

(3.9-14.7)

 

Larynx

45

12.08

 

3.73

8.0

(5.0-11.7)

 

Kidney

45

21.47

 

2.10

5.7

(2.8-9.4)

 

Leukaemia

30

16.07

 

1.87

3.4

(1.0-6.5)

Melanoma of skin

Leukaemia

19

6.22

20,881

3.06

6.1

(2.5-11.2)

Prostate

Colorectum

830

692.73

230,582

1.20

6.0

(3.5-8.5)

 

Bladder

406

291.02

 

1.40

5.0

(3.3-6.8)

Testis

Kidney

10

2.38

19,448

4.20

3.9

(1.2-8.2)

Bladder

Lung, bronchus and trachea

295

94.45

38,002

3.12

52.8

(44.2-62.2)

 

Prostate

398

257.66

 

1.54

36.9

(26.9-47.7)

 

Head and neck

55

27.02

 

2.04

7.4

(3.8-11.7)

 

Larynx

28

10.96

 

2.55

4.5

(2.0-7.8)

 

Stomach

38

23.71

 

1.60

3.8

(0.8-7.5)

Kidney

Prostate

269

162.00

28,385

1.66

37.7

(26.7-49.7)

 

Bladder

39

24.55

 

1.59

5.1

(1.1-10.1)

Thyroid gland

Prostate

34

20.08

7,369

1.69

18.9

(4.7-37.2)

 

Leukaemia

5

1.50

 

3.33

4.7

(0.1-13.8)

Hodgkin's disease

Lung, bronchus and trachea

23

5.72

8,338

4.02

20.7

(10.6-34.5)

 

Non-Hodgkin’s lymphoma

6

1.33

 

4.50

5.6

(1.0-14.1)

 

Oesophagus

4

0.93

 

4.29

3.7

(0.2-11.2)

Non-Hodgkin’s lymphoma

Lung, bronchus and trachea

76

46.84

26,008

1.62

11.2

(5.0-18.6)

 

Leukaemia

21

8.50

 

2.47

4.8

(1.7-9.1)

 

Bladder

30

17.70

 

1.70

4.7

(1.0-9.7)

 

Stomach

18

10.21

 

1.76

3.0

(0.2-7.0)

Chronic lymphatic leukaemia

Lung, bronchus and trachea

56

27.69

11,261

2.02

25.1

(13.0-40.0)

Colorectum

41

27.78

 

1.48

11.7

(1.5-24.7)

 

Hodgkin’s disease

4

0.39

 

10.26

3.2

(0.6-8.7)

  1. SPC, second primary cancer; O, Observed; E, Expected; PYR, person-years at risk; SIR, standardized incidence ratio; EAR, excess absolute risk; CI, confidence interval.
  2. aAll P < .05.
  3. bNumber of excess cancers per 10,000 person-years at risk.
  4. cSPC occurring in a different subsite as the first primary cancer.